Table 4 Comparison of QoL scores between the two groups
|  | Autotransplantation group (n = 84) | Preservation group (n = 192) | P |
|---|---|---|---|
THYCA-QoL symptom scales | |||
 Neuromuscular | 22.2 (5.6–27.8) | 22.2 (11.1–22.2) | 0.975 |
 Voice | 0.0 (0.0–16.7) | 0.0 (0.0–33.3) | 0.158 |
 Concentration | 16.7 (0.0–33.3) | 16.7 (0.0–33.3) | 0.824 |
 Sympathetic | 16.7 (0.0–33.3) | 16.7 (0.0–33.3) | 0.222 |
 Throat/mouth problems | 11.1 (0.0–22.2) | 11.1 (0.0–22.2) | 0.171 |
 Psychological | 25.0 (8.3–37.5) | 25.0 (16.7–33.3) | 0.853 |
 Sensory | 16.7 (0.0–33.3) | 16.7 (16.7–33.3) | 0.166 |
 Problems with scar | 0.0 (0.0–33.3) | 0.0 (0.0–33.3) | 0.258 |
 Felt chilly | 0.0 (0.0–33.3) | 0.0 (0.0–33.3) | 0.959 |
 Tingling hands/feet | 0.0 (0.0–33.3) | 0.0 (0.0–33.3) | 0.614 |
 Gained weight | 33.3 (0.0–33.3) | 33.3 (0.0–33.3) | 0.502 |
 Headache | 33.3 (0.0–33.3) | 0.0 (0.0–33.3) | 0.060 |
 Less interest in sex | 33.3 (0.0–33.3) | 33.3 (0.0–33.3) | 0.892 |
EORTC QLQ-C30 functioning scales | |||
 Global health | 66.7 (50.0–83.3) | 66.7 (50.0–83.3) | 0.684 |
 Physical functioning | 93.3 (86.7–100.0) | 93.3 (86.7–100.0) | 0.225 |
 Role functioning | 100.0 (100.0–100.0) | 100.0 (100.0–100.0) | 0.148 |
 Emotional functioning | 83.3 (66.7–100.0) | 83.3 (66.7–91.7) | 0.562 |
 Cognitive functioning | 83.3 (66.7–100.0) | 83.3 (66.7–100.0) | 0.638 |
 Social functioning | 100.0 (83.3–100.0) | 100.0 (83.3–100.0) | 0.414 |
EORTC QLQ-C30 symptom scales | |||
 Pain | 0.0 (0.0–16.7) | 0.0 (0.0–16.7) | 0.425 |
 Fatigue | 22.2 (0.0–33.3) | 22.2 (11.1–33.3) | 0.271 |
 Nausea and vomiting | 0.0 (0.0–0.0) | 0.0 (0.0–0.0) | 0.054 |
 Dyspnea | 0.0 (0.0–33.3) | 0.0 (0.0–33.3) | 0.807 |
 Insomnia | 16.7 (0.0–33.3) | 33.3 (0.0–33.3) | 0.170 |
 Appetite loss | 0.0 (0.0–0.0) | 0.0 (0.0–0.0) | 0.393 |
 Constipation | 0.0 (0.0–33.3) | 0.0 (0.0–33.3) | 0.464 |
 Diarrhea | 0.0 (0.0, 0.0) | 0.0 (0.0–0.0) | 0.430 |
 Financial difficulties | 0.0 (0.0–0.0) | 0.0 (0.0–0.0) | 0.782 |